Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
skin aging
MeSH D015595 - skin aging
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D012879:
Skin physiological phenomena
0 Companies
0 Drugs
Success rate
D015595:
Skin aging
1 Company
1 Drug
$
Success rate
Events Timeline
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Evolus
Botulinum toxin type a
Nuceiva
2019-09-27
Clinical Trials
Historical Success Rate
Phase 1
0
%
0/0
Phase 2
75
%
3/4
Phase 3
44
%
4/9
Approved:
1
Overall Success rate:
0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Evolus
Botulinum toxin type a
,
PRABOTULINUMTOXINA-XVFS
,
Sodium chloride
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use